Ashish Nimgaonkar

Ashish Nimgaonkar

Company: Glyscend Therapeutics

Job title: Co-Founder & Chief Medical Officer

Seminars:

Panel – Lessons Learnt from Obesity & Diabetes to Inform Market Access Strategies for Wider Cardiometabolic Indications 4:30 pm

Understanding common barriers to patient access and affordability for treatments in these areas to consider how cost-sharing arrangements can be effectively navigated Understanding how availability of existing treatments and the pipeline of new therapies differ across CVRM disease areas effects market access dynamics Uncovering best practices in market access that have been applied in one…Read more

day: Conference Day One

Focussed Strategy Discussions – An opportunity to unite with the executives working in specific disease areas to brainstorm effective market access strategies and take actionable insights to tackle disease specific challenges 11:00 am

Diabetes & Weight Management MASH & Liver Disease CKD & Renal DiseaseRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.